Pathogenic background for treatment of ascites and the hepatorenal syndrome.

Keyphrases

• Hepatorenal Syndrome 100%
• Ascites 100%
• Portal Hypertension 50%
• Refractory Ascites 25%
• Liver Transplantation 25%
• Cirrhosis Complications 25%
• Renal Vasoconstriction 25%
• Diuretic Therapy 25%
• Arterial Hypotension 25%
• Salt Restriction 25%
• Cardiovascular Dysfunction 25%
• Modern Treatment 25%
• Arterial Vasospasm 25%
• Quality of Life 25%
• Vasopressin V2 Receptor Antagonist 25%
• Loop Diuretics 25%
• New Treatment Options 25%
• Liver Insufficiency 25%
• Renal Function 25%
• Poor Prognosis 25%
• Fluid Retention 25%
• Spironolactone 25%
• Volume Expansion 25%
• Vasodilator 25%
• Transjugular Intrahepatic Portosystemic Shunt 25%
• Cirrhosis 25%
• Liver Function 25%
• Large-volume Paracentesis 25%
• Disease Course 25%
• Central Hypovolemia 25%

Medicine and Dentistry

• Hepatorenal Syndrome 100%
• Ascites 100%
• Portal Hypertension 40%
• Liver Cirrhosis 40%
• Spironolactone 20%
• Vasoconstriction 20%
• Fluid Retention 20%
• Loop Diuretic Agent 20%
• Diuretic Therapy 20%
• Quality of Life 20%
• Transjugular Intrahepatic Portosystemic Shunt 20%
• Cardiovascular System 20%
• Sodium Restriction 20%
• Diseases 20%
• Liver Function 20%
• Liver Failure 20%
• Liver Transplantation 20%
• Paracentesis 20%
• Vasoconstrictor 20%
• Vasodilatation 20%
• Hypotension 20%
• Kidney Function 20%
• Hypovolemia 20%
• Receptor Antagonist 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Ascites 100%
• Hepatorenal Syndrome 100%
• Liver Cirrhosis 40%
• Portal Hypertension 40%
• Vasopressin V2 Receptor 20%
• Receptor Antagonist 20%
• Liver Failure 20%
• Table Salt 20%
• Hypovolemia 20%
• Diseases 20%
• Hypotension 20%
• Loop Diuretic Agent 20%
• Spironolactone 20%
• Diuretic Therapy 20%